EntoPrime ApS: Financial statements 2025
CVR: 44434903
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
EntoPrime ApS (CVR 44434903) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 543,426 and a net result of DKK 193,645. Equity in the 2025 report amounted to DKK 520,890. The solvency ratio was 53.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 543,426
- Profit/Loss
- DKK 193,645
- Equity
- DKK 520,890
- Total Assets
- DKK 975,251
- Employees
- 1
Official annual report
How creditworthy is EntoPrime ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
EntoPrime ApS has published its interim report for the period November 16, 2023 to December 31, 2024.
About EntoPrime ApS
EntoPrime ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anton Gligorescu. The board consists of Claus Bundgaard Nielsen (chair), Anton Gligorescu and Daniel Olariu. The company is owned by Benoni Living ApS, EntoPrime Holding ApS and Daniel Olariu. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 543,426 and a net result of DKK 193,645. Equity in the 2025 report amounted to DKK 520,890.